Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

51.96 +0.56 (+1.09%)
Official Closing Price Updated: 7:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
27 28 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Shares of TransMedics Group, Inc. (NASDAQ: TMDX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning! 
Via InvestorPlace
Earnings Preview: Hims & Hers Health
Via Benzinga
Where Will Hims & Hers Stock Be in 5 Years?
This unique telemedicine company looks poised for a bright future. 
Via The Motley Fool
1 Healthcare Stock to Buy Hand Over Fist Going Into 2024
Hims & Hers Health is growing at an unprecedented rate. 
Via The Motley Fool
bluebird bio stock is ripe for a 400% institutional short squeeze
Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in 
Via MarketBeat
Topics Economy
Exposures Interest Rates
HIMS Stock Breaks Out On Powerful Turnaround Quarter
"In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability.": CEO Andrew Dudum 
Via Investor's Business Daily
Bitcoin Above $55K Gets Marathon, Riot Platforms Trending — Zoom Video, Hims & Hers, Tesla Also On Investors' Radars Today
On Monday, the leading U.S. indices concluded on a negative note, with the Dow Jones Industrial Average finishing 0.16% down at 39,069.23, the S&P 500 dropping nearly 0.4% to 5,069.53, and the Nasdaq... 
Via Benzinga
Topics Stocks
Exposures US Equities
Hims & Hers Health Stock Climbs Following Q4 Earnings Beat, Revenue Beat, Guidance Above Estimates
Hims & Hers Health reported quarterly earnings of 1 cent per share which beat the analyst consensus estimate of losses of 3 cents per share. The company reported quarterly sales of $246.62 million... 
Via Benzinga
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Hims & Hers Health, Inc.
Via Business Wire
This healthcare stock making a buzz with 160% growth
Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them. 
Via MarketBeat
Topics Economy
Exposures Economy
Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
From Hims & Hers Health, Inc.
Via Business Wire
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. 
Via Benzinga
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
From Hims & Hers Health, Inc.
Via Business Wire
3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024
Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Growth Stocks to Buy and Hold Forever: January 2024
Growth stocks haven't kept up with wider market growth, creating a unique opportunity to capture long-term upside with these companies. 
Via InvestorPlace
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
Healthcare is nearly a fifth of America's economy. Ride these high-flying healthcare stocks to monster gains. 
Via The Motley Fool
Topics Economy
Exposures Economy
3 Stocks to Profit from the Telehealth Transformation
Telehealth stocks capture healthcare and medicine's future but don't bet the bank on a company that can't cut it. 
Via InvestorPlace
Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
From Hims & Hers Health, Inc.
Via Business Wire
Underestimating This Stock Could Be Wall Street's Biggest Mistake in 2024
Hard numbers and the CEO's own words point to shares exploding next year. 
Via The Motley Fool
Weight Watchers gains from Oprah’s GLP-1 weight-loss
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
2023 Year In Review
The S&P 500 had a strong year in 2023, returning about 24% to investors from the beginning of the year to the end. Some of that was a bounce back from a poor 2022 when it was down over 11%. 
Via Talk Markets
Topics Stocks
Exposures US Equities
The 3 Hottest Telehealth Stocks to Watch in 2024
Uncover the hottest telehealth stocks for 2024, on the back of a market projected to reach a whopping $504.2 billion by 2030. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
LifeMD expands telehealth GLP-1weight-loss service with Medifast
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing 
Via MarketBeat
My 2024 Financial Resolution: Buying More of These 3 Stocks
These stocks are still screaming buys for my long-term portfolio. 
Via The Motley Fool
Ozempic vs. Mounjaro:: Battle of the bulge
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage 
Via MarketBeat
Exposures Product Safety
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
From Hims & Hers Health, Inc.
Via Business Wire
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback